Speeding up early drug development
Therapeutic molecules of clinical-grade quality. From 1 mg. Ready to ship.
Therapeutic Molecules Biologics ADCs Monoclonal antibodies Bispecific antibodies Reference products
aliquoted from medicines
Drug aliquots for R&D
- Immediately available
- From 1 vial per order
- 2-4 weeks lead time
- Minimum order applies
best selling products
Amivantamab
PES0C04
Enfortumab Vedotin
3PA0169
Teclistamab
AU1230P5
Rituximab
N7734B02
Brentuximab vedotin
12710715
Lebrikizumab
1A
Paclitaxel
3B026B
Golimumab
NDS3PML
Certolizumab Pegol
378984
Cetuximab
G023GS
Analytical data service
Explore our comprehensive suite of analytical
methods to analyze biologic molecules.
- Comprehensive Analysis Package
- Individual Analysis Package
- Taylored Analysis Package
- Therapeutic drugs as aliquots
- Multiple drug batches
- Consumable, so no license needed
- Prompt Delivery
- Fraction of the original drug price
Evidentic – fast, accurate, secure
Our products are empowering researchers worldwide
"After having great difficulty sourcing therapeutic antibodies in the small quantities required for research purposes, Evidentic has been a revelation! I have found them to be very friendly and prompt in replying to orders and queries."
Dr. Cassey McRae
Senior R&D Scientist at Avacta Life Sciences
"Evidentic gives rapid access to originator biologics and different batches. For biosimilar developers and regulators, it will shorten the time to gauge the analytical acceptance range for multiple CQAs of biotherapeutics."
Prof. Dr. Henning von Horsten
Life Science Engineering, HTW Berlin
“Evidentic was the only source that offered small aliquots of original therapeutic mAbs at an affordable price range. The aliquots came in an easy-to-use-and-store format that was apt for my research purpose.”
Ivanna Hrynchak
PhD Student ICNAS, Universidade de Coimbra
“We develop innovative and biosimilar mAbs for a global market. Evidentic’s aRMPs are a great source of cost-efficient reference products for our research and development program.”
Tom H. Jin, M.D.
Director of Process Development
"Evidentic is a new source of cost-efficient therapeutic mAbs for our immonassays. And easy to order!”
Thibault Jonckheere
CEO
"Evidentic drug aliquots have helped us speed up our antibody characterization assays and selection of clonal cell lines. An easy and reliable source!"
Prof. (emeritus) Dr. Florian Wurm
CSO & Founder
”Evidentic can supply different batches of reference products for pre-clinical research. The quick access allows for ad-hoc ordering, keeps costs down and makes a headstart possible!”
Anjan Selz
Vice President Head of Biosimilars EMEA
“Evidentic drug aliquots have significantly reduced our development cycle time and strengthened our ability to do detailed [protein] characterization”
Dr Stephan Schultz
Team Leader of Analytics/DSP
Recent Articles
News
Incubators: Cultivating Innovation in Life Sciences
Incubators, by offering resources and guidance, fuel innovation in life sciences by accelerating progress, boosting success rates, and fostering a vibrant ecosystem.
Scientific Resources
Solubility of ADCs: influencing factors and optimization tips
The solubility of ADCs is a critical factor not only for clinical efficacy and safety, but also for manufacturability. Here, we will discuss the factors that affect the solubility of ADCs and how to optimize their solubility.
Scientific Resources
How to identify the right molecule for your assay
Why you should distinguish clinical-grade from research-grade molecules
Meet Us
25-27 September 2024
Hybrid European Bioassay Conference
Hilton Prague Hotel
Pobrežní 311/1, Prague, 186 00, Czech Republic
08–10 October 2024
CPHI Milan
Fiera Milano, Milan, Italy
Fiera Milano, Strada Statale Sempione, 28, 20017 Rho MI, Italy